Different D-dimer assays with age-adjusted cutoffs to exclude pulmonary embolism: secondary analysis of ADJUST-PE study
Journal of Thrombosis and Haemostasis · 2025-08 · 23 (8) · 2531-2539
DOI: 10.1016/j.jtha.2025.04.007 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-08. Verfasst von Helia Robert-Ebadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Angiology and Hemostasis, Department of Medicine, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland. Electronic addre…. Hauptthemen laut MEDLINE: Pulmonary Embolism, Fibrin Fibrinogen Degradation Products. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Siemens AG, Trombosestichting Nederland, bioMérieux.
Abstract (Originalsprache)
BACKGROUND: The multicenter prospective ADJUST-PE study proved the safety of an age-adjusted D-dimer (AADD) cutoff to exclude pulmonary embolism (PE). OBJECTIVES: Assess the safety of different D-dimer (DD) assays using AADD in patients included in ADJUST-PE in Geneva compared with the originally used VIDAS DD Exclusion test. METHODS: This was a preplanned secondary analysis. The VIDAS DD Exclusion test was repeated to ensure reproducible results in thawed samples. Other tests performed were Innovance DD test, STA Liatest, Tina-quant DD, and the point-of-care LumiraDx test. The main outcome was venous thromboembolic risk (VTE) at initial testing or within 3 months after PE exclusion by a negative DD test using AADD ("failure rate"). The secondary outcome measure was to compare each assay with VIDAS in the classification of patients as having a negative vs positive AADD result. RESULTS: A total of 602 patients were included and 597 were available for analysis. Fourteen percent had PE confirmed at baseline. Failure rates were
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Angiology and Hemostasis, Department of Medicine, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland. Electronic address: helia.robert-ebadi@hug.ch.
- Division of Clinical Epidemiology, Department of Health and Community Medicine, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
- Hemostasis Laboratory, Diagnostic Department, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
- Division of Angiology and Hemostasis, Department of Medicine, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
- Division of Angiology and Hemostasis, Department of Medicine, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland; Hemostasis Laboratory, Diagnostic Department, Faculty of Medicine, Geneva University H…
Förderung
- Siemens AG
- Trombosestichting Nederland
- bioMérieux
- Swiss National Science Foundation
Zitieren
APA
Robert-Ebadi, H., Combescure, C., Bulla, O., Righini, M., & Fontana, P. (2025). Different D-dimer assays with age-adjusted cutoffs to exclude pulmonary embolism: secondary analysis of ADJUST-PE study. Journal of Thrombosis and Haemostasis, 23(8), 2531-2539. https://doi.org/10.1016/j.jtha.2025.04.007
Vancouver
Robert-Ebadi H, Combescure C, Bulla O, Righini M, Fontana P. Different D-dimer assays with age-adjusted cutoffs to exclude pulmonary embolism: secondary analysis of ADJUST-PE study. Journal of Thrombosis and Haemostasis. 2025;23(8):2531-2539. doi:10.1016/j.jtha.2025.04.007
BibTeX
@article{RobertEbadi2025,
author = {Robert-Ebadi, Helia and Combescure, Christophe and Bulla, Oana and Righini, Marc and Fontana, Pierre},
title = {Different D-dimer assays with age-adjusted cutoffs to exclude pulmonary embolism: secondary analysis of ADJUST-PE study},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
volume = {23},
number = {8},
pages = {2531--2539},
doi = {10.1016/j.jtha.2025.04.007}
}
EUVIMED